According to FT, citing sources close to the matter, the offer would price Hologic’s shares between $70 and $72, substantially above Friday’s closing price of $54.28. Investors appeared to react to ...

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

The Financial Times reported yesterday that a duo of private equity firms approached Hologic (Nasdaq: HOLX) about a potential ...

The biggest reason for this surge was Hologic's impressive earnings report ... basically suggests that everyone's undervaluing this stock. That's tough to agree with, especially with the way ...

Following the earnings release, the stock rose 1.1% to $83.39 at yesterday’s close. Let’s briefly go through Hologic’s performance ... led by a 10.5% surge in Molecular Diagnostics.

The stock's fall snapped a two-day winning streak.

Hologic declined a $16 billion buyout bid from TPG and Blackstone as it faces falling shares and tariff-related headwinds, ...

Hologic stock (NASDAQ NDAQ: HOLX), a medical devices company focused on women’s health, has seen a 19% fall this year, faring slightly better than the broader S&P500 index, down 24%. Even if we ...

Investing.com -- Hologic Inc (NASDAQ:HOLX) stock soared 14% following a report from the Financial Times that private equity groups TPG and Blackstone (NYSE:BX) approached the company with a buyout ...

This was the stock's second consecutive day of losses.